logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
B

Byoung Yong Shim

The Catholic University of Korea
H指数:24
被引数:2,005

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Lazertinib Plus Pemetrexed and Carboplatin in Patients With EGFR-Mutant Advanced Non-Small Cell Lung Cancer after Progression on Lazertinib

拉泽替尼联合培美曲塞和卡铂用于拉泽替尼治疗后进展的<em>EGFR</em>突变晚期非小细胞肺癌患者

European Journal of Cancer
IF7.1
2026-10-080
OAAI
Min Hee Hong; Byoung Yong Shim; Chang Gon Kim; Young Saing Kim; Seoyoung Lee; Youngjoo Lee; Beung-Chul Ahn; Myung-Ju Ahn; Jin Seok Ahn; Sehhoon Park; Ja Hyun Yeo; Sook Hee Hong; In Hwan Jang; Ki Hyeong Lee; Hye Ryun Kim
Author Correction: DKN-01 and tislelizumab as second-line therapy in DKK1-high gastroesophageal adenocarcinoma: DisTinGuish trial part B

作者更正: DKN-01和tislelizumab作为DKK1-high胃食管腺癌的二线治疗: 区分试验B部分

Nature Communications
IF15.7
2026-02-060
OAAI
Keun-Wook Lee; Devalingam Mahalingam; Byoung Yong Shim; In-Ho Kim; Do-Youn Oh; Hope Uronis; Sun Jin Sym; Mohamad Sonbol; Khaldoun Almhanna; Mohamedtaki A. Tejani; Beodeul Kang; Michael H. Kagey; Melissa Stilian; Calvin Jia; Cynthia A. Sirard; Rachel Altura; Jaffer A. Ajani; Samuel J. Klempner
Perioperative durvalumab plus chemotherapy plus new agents for resectable non-small-cell lung cancer: the platform phase 2 NeoCOAST-2 trial
Nature Medicine
IF50
2025-05-310
OAAI
Tina Cascone; Laura Bonanno; Florian Guisier; Amelia Insa; Moishe Liberman; Olivier Bylicki; Lorenzo Livi; Thomas Egenod; Romain Corre; Dong-Wan Kim; Maria Rosario Garcia Campelo; Mariano Provencio Pulla; Byoung Yong Shim; Giulio Metro; Jaafar Bennouna; Agata A. Bielska; Alula R. Yohannes; Yun He; Adam Dowson; Gozde Kar; Lara McGrath; Rakesh Kumar; Italia Grenga; Jonathan Spicer; Patrick M. Forde
Exploratory biomarker analysis in EGFR mutated NSCLC patients who treated with atezolizumab plus bevacizumab and chemotherapy from phase III ATTLAS trial

ATTLAS III期试验中接受阿替利珠单抗联合贝伐珠单抗和化疗治疗的EGFR突变NSCLC患者的探索性生物标志物分析

ANNALS OF ONCOLOGY
IF65.4
2024-12-010
PRE
Kim, H.; Park, S.; Kim, T. M.; Han, J-Y.; Lee, G-W.; Shim, B. Y.; Lee, Y-G.; Kim, S-W.; Ock, C-Y.; Hwang, S.; Lee, Y.; Kim, R.; Jung, H. A.; Sun, J-M.; Lee, S-H.; Ahn, J. S.; Ahn, M-J.
Leveraging innate and adaptive immunity with AFM24 and atezolizumab in metastatic gastric cancer

利用AFM24和atezolizumab增强固有免疫和适应性免疫在转移性胃癌中的应用

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Santa Gadea, O. Saavedra; Oberoi, A.; Lopez, J. S.; Cervantes, A.; Ponz-Sarvise, M.; Kim, H. R.; El-Khoueiry, A. B.; Shim, B.; Kim, J. W.; Boni, V.; Lugowska, I.; Szczylik, C.; Rogowski, W.; Mandziuk, S.; Ramlau, R.; Gaertner, U.; Lutkewitz, S.; Schuetz, D.; Emig, M.; Morales-Espinosa, D.
A phase 2 multicenter study of docetaxel-PM and trastuzumab-pkrb combination therapy in recurrent or metastatic salivary gland carcinomas

多西他赛-PM和曲妥珠单抗-pkrb联合治疗复发或转移性涎腺癌的2期多中心研究

CANCER
IF5.1
2023-05-286
PRE
Lee, Jiyun; Park, Sehhoon; Jung, Hyun Ae; Lee, Se-Hoon; Seo, Seyoung; Kim, Sung-Bae; Kim, Ji-Won; Lee, Keun-Wook; Kang, Eun Joo; Kim, Ju Won; Choi, Yoon Ji; Shim, Byoung-Yong; An, Ho-Jung; Park, Lee Chun; Shin, Seong Hoon; Kim, Jae-Joon; Oh, So Yeon; Kim, Min Kyoung; Ahn, Myung-Ju
A Randomized Phase III Study of Patients With Advanced Gastric Adenocarcinoma Without Progression After Six Cycles of XELOX (Capecitabine Plus Oxaliplatin) Followed by Capecitabine Maintenance or Clinical Observation
gastric cancer
IF3.8
2023-01-011
OAAI
Lee, Guk Jin; Kim, Hyunho; Cho, Sung Shim; Park, Hyung Soon; An, Ho Jung; Woo, In Sook; Byun, Jae Ho; Hong, Ji Hyung; Ko, Yoon Ho; Sun, Der Sheng; Won, Hye Sung; Jin, Jong Youl; Park, Ji Chan; Kim, In-Ho; Roh, Sang Young; Shim, Byoung Yong
Margetuximab with retifanlimab as first-line therapy in HER2D/PD-L1D unresectable or metastatic gastroesophageal adenocarcinoma: MAHOGANY cohort A

Margetuximab和retifanlimab作为一线治疗HER2D/PD-L1D不可切除或转移性胃食管腺癌: 桃花心木队列A

ESMO OPEN
IF8.3
2022-10-0131
OAAI
Catenacci, D. V. T.; Kang, Y-K; Yoon, H. H.; Shim, B. Y.; Kim, S. T.; Oh, D-Y; Spira, A., I; Ulahannan, S., V; Avery, E. J.; Boland, P. M.; Chao, J.; Chung, H. C.; Gardner, F.; Klempner, S. J.; Lee, K-W; Oh, S. C.; Peguero, J.; Sonbol, M. B.; Shen, L.; Moehler, M.; Sun, J.; Li, D.; Rosales, M. K.; Park, H.
Totality outcome of afatinib sequential treatment in patients with EGFR mutation-positive non-small-cell lung cancer in South Korea (TOAST): Korean Cancer Study Group (KCSG) LU-19-22

韩国EGFR突变阳性非小细胞肺癌患者阿法替尼序贯治疗的总体结果 (TOAST): 韩国癌症研究组 (KCSG) LU-19-22

TRANSLATIONAL LUNG CANCER RESEARCH
IF3.5
2022-07-0112
OAAI
Jung, Hyun Ae; Hong, Min Hee; Lee, Hyun Woo; Lee, Kyung Hee; Kim, Il Hwan; Min, Young Joo; Ahn, Hee Kyung; Shim, Byoung Yong; Choi, Yoon Hee; Lee, Yun-Gyoo; Kim, Jeong A.; Jang, Joung Soon; Shin, Seong-Hoon; Park, Keon Uk; Kang, Jin Hyoung; Park, Keunchil

研究方向

暂未获取到该数据
S
Sung Hwan Kim
H 指数:30论文数:219被引数:3,015
H
Ho Jung An
H 指数:24论文数:150被引数:2,782
D
Dae Young Zang
H 指数:36论文数:311被引数:1.2万
A
Alexander I. Spira
H 指数:67论文数:943被引数:2.8万
H
Hyun Cheol Chung
H 指数:86论文数:1,687被引数:5.5万
H
Hyun Ae Jung
H 指数:30论文数:312被引数:4,631
J
Jong Hoon Lee
H 指数:31论文数:208被引数:3,233
H
Hyeon‐Min Cho
H 指数:22论文数:107被引数:1,378
M
Min Hee Hong
H 指数:39论文数:657被引数:6,661
S
Sehhoon Park
H 指数:22论文数:154被引数:1,904